nodes	percent_of_prediction	percent_of_DWPC	metapath
Fenoldopam—hypertension—adrenal gland cancer	0.964	1	CtDrD
Fenoldopam—DRD2—Signaling by GPCR—TSHR—adrenal gland cancer	4.17e-05	0.00115	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR ligand binding—POMC—adrenal gland cancer	4.16e-05	0.00114	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	4.13e-05	0.00114	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—GNRHR—adrenal gland cancer	4.13e-05	0.00113	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—TSHR—adrenal gland cancer	4.11e-05	0.00113	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—ZNRF3—adrenal gland cancer	4.03e-05	0.00111	CbGpPWpGaD
Fenoldopam—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	4.03e-05	0.00111	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—TSHR—adrenal gland cancer	4.02e-05	0.0011	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—PRKACA—adrenal gland cancer	3.96e-05	0.00109	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—CDC42—adrenal gland cancer	3.96e-05	0.00109	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—PRKACA—adrenal gland cancer	3.91e-05	0.00107	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—ZNRF3—adrenal gland cancer	3.88e-05	0.00107	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SH3KBP1—adrenal gland cancer	3.84e-05	0.00105	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—IGF2—adrenal gland cancer	3.82e-05	0.00105	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—GNAS—adrenal gland cancer	3.78e-05	0.00104	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR ligand binding—POMC—adrenal gland cancer	3.75e-05	0.00103	CbGpPWpGaD
Fenoldopam—DRD1—Circadian rythm related genes—TP53—adrenal gland cancer	3.74e-05	0.00103	CbGpPWpGaD
Fenoldopam—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	3.74e-05	0.00103	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—TSHR—adrenal gland cancer	3.73e-05	0.00103	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—CDC42—adrenal gland cancer	3.7e-05	0.00102	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—GNRH1—adrenal gland cancer	3.66e-05	0.00101	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—CDC42—adrenal gland cancer	3.65e-05	0.001	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—GNRH1—adrenal gland cancer	3.61e-05	0.000992	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—ZNRF3—adrenal gland cancer	3.61e-05	0.000992	CbGpPWpGaD
Fenoldopam—DRD5—GPCR downstream signaling—POMC—adrenal gland cancer	3.59e-05	0.000985	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—GNAS—adrenal gland cancer	3.54e-05	0.000972	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—PRKACA—adrenal gland cancer	3.53e-05	0.00097	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—PRKACA—adrenal gland cancer	3.52e-05	0.000968	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR ligand binding—POMC—adrenal gland cancer	3.51e-05	0.000964	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—GNAS—adrenal gland cancer	3.49e-05	0.000959	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—RRM1—adrenal gland cancer	3.48e-05	0.000956	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—SDHD—adrenal gland cancer	3.48e-05	0.000956	CbGpPWpGaD
Fenoldopam—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	3.46e-05	0.000951	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR ligand binding—POMC—adrenal gland cancer	3.45e-05	0.000948	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—CDC42—adrenal gland cancer	3.36e-05	0.000924	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—SPRY2—adrenal gland cancer	3.35e-05	0.00092	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—CDC42—adrenal gland cancer	3.32e-05	0.000911	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—SPRY2—adrenal gland cancer	3.3e-05	0.000907	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—PRKACA—adrenal gland cancer	3.3e-05	0.000906	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—CDC42—adrenal gland cancer	3.3e-05	0.000906	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TSHR—adrenal gland cancer	3.26e-05	0.000896	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—GNRH1—adrenal gland cancer	3.26e-05	0.000896	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—POMC—adrenal gland cancer	3.26e-05	0.000894	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—PRKACA—adrenal gland cancer	3.25e-05	0.000892	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TSHR—adrenal gland cancer	3.22e-05	0.000884	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—GNAS—adrenal gland cancer	3.21e-05	0.000883	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—MED12—adrenal gland cancer	3.19e-05	0.000877	CbGpPWpGaD
Fenoldopam—DRD2—GPCR ligand binding—POMC—adrenal gland cancer	3.18e-05	0.000874	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—GNAS—adrenal gland cancer	3.17e-05	0.000871	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—GNAS—adrenal gland cancer	3.15e-05	0.000866	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—CDC42—adrenal gland cancer	3.08e-05	0.000846	CbGpPWpGaD
Fenoldopam—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	3.07e-05	0.000845	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—MEN1—adrenal gland cancer	3.07e-05	0.000843	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR ligand binding—POMC—adrenal gland cancer	3.07e-05	0.000842	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—GNRH1—adrenal gland cancer	3.05e-05	0.000837	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—CDC42—adrenal gland cancer	3.03e-05	0.000833	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—MEN1—adrenal gland cancer	3.03e-05	0.000831	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—GNRH1—adrenal gland cancer	3e-05	0.000824	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—CDC42—adrenal gland cancer	2.99e-05	0.000823	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—PRKACA—adrenal gland cancer	2.99e-05	0.000822	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CDC42—adrenal gland cancer	2.99e-05	0.000821	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—SPRY2—adrenal gland cancer	2.98e-05	0.000819	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—GNAS—adrenal gland cancer	2.94e-05	0.000809	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TSHR—adrenal gland cancer	2.91e-05	0.000798	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—GNAS—adrenal gland cancer	2.9e-05	0.000796	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—PRKACA—adrenal gland cancer	2.88e-05	0.000792	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IGF2—adrenal gland cancer	2.88e-05	0.000792	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—GNAS—adrenal gland cancer	2.86e-05	0.000786	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—GNAS—adrenal gland cancer	2.86e-05	0.000785	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR ligand binding—POMC—adrenal gland cancer	2.85e-05	0.000783	CbGpPWpGaD
Fenoldopam—DRD2—Circadian rythm related genes—TP53—adrenal gland cancer	2.83e-05	0.000777	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—CDC42—adrenal gland cancer	2.8e-05	0.000769	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—CDC42—adrenal gland cancer	2.8e-05	0.000768	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—IGF1R—adrenal gland cancer	2.79e-05	0.000765	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—SPRY2—adrenal gland cancer	2.79e-05	0.000765	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—GNRH1—adrenal gland cancer	2.76e-05	0.000759	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—CDC42—adrenal gland cancer	2.75e-05	0.000756	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—SPRY2—adrenal gland cancer	2.74e-05	0.000753	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—MEN1—adrenal gland cancer	2.73e-05	0.000751	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TSHR—adrenal gland cancer	2.71e-05	0.000746	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—CDC42—adrenal gland cancer	2.69e-05	0.00074	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—PRKACA—adrenal gland cancer	2.68e-05	0.000736	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—GNAS—adrenal gland cancer	2.67e-05	0.000734	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TSHR—adrenal gland cancer	2.67e-05	0.000734	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—GNAS—adrenal gland cancer	2.67e-05	0.000734	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—GNRH1—adrenal gland cancer	2.66e-05	0.000731	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—GNAS—adrenal gland cancer	2.63e-05	0.000723	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—MED12—adrenal gland cancer	2.59e-05	0.000713	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—GNAS—adrenal gland cancer	2.57e-05	0.000707	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—MEN1—adrenal gland cancer	2.55e-05	0.000701	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—CDC42—adrenal gland cancer	2.54e-05	0.000697	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—SPRY2—adrenal gland cancer	2.53e-05	0.000694	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—MEN1—adrenal gland cancer	2.51e-05	0.00069	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—CDC42—adrenal gland cancer	2.5e-05	0.000687	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—GNRH1—adrenal gland cancer	2.47e-05	0.00068	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TSHR—adrenal gland cancer	2.46e-05	0.000677	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—CDC42—adrenal gland cancer	2.45e-05	0.000672	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—SPRY2—adrenal gland cancer	2.44e-05	0.000669	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—GNAS—adrenal gland cancer	2.43e-05	0.000666	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TERT—adrenal gland cancer	2.4e-05	0.000659	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—GNAS—adrenal gland cancer	2.39e-05	0.000657	CbGpPWpGaD
Fenoldopam—DRD1—GPCR downstream signaling—POMC—adrenal gland cancer	2.38e-05	0.000654	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TSHR—adrenal gland cancer	2.37e-05	0.000652	CbGpPWpGaD
Fenoldopam—ADRA1D—GPCR downstream signaling—POMC—adrenal gland cancer	2.35e-05	0.000646	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—PRKACA—adrenal gland cancer	2.34e-05	0.000643	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—GNAS—adrenal gland cancer	2.34e-05	0.000642	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PRKACA—adrenal gland cancer	2.33e-05	0.00064	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—MEN1—adrenal gland cancer	2.32e-05	0.000636	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—PRKACA—adrenal gland cancer	2.31e-05	0.000635	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—CDC42—adrenal gland cancer	2.27e-05	0.000624	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—SPRY2—adrenal gland cancer	2.26e-05	0.000622	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—MEN1—adrenal gland cancer	2.23e-05	0.000613	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TSHR—adrenal gland cancer	2.21e-05	0.000606	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—GNAS—adrenal gland cancer	2.17e-05	0.000597	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—POMC—adrenal gland cancer	2.16e-05	0.000594	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—POMC—adrenal gland cancer	2.13e-05	0.000586	CbGpPWpGaD
Fenoldopam—ADRA2B—GPCR downstream signaling—POMC—adrenal gland cancer	2.12e-05	0.000583	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—BAD—adrenal gland cancer	2.09e-05	0.000573	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—PRKACA—adrenal gland cancer	2.09e-05	0.000573	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—MEN1—adrenal gland cancer	2.07e-05	0.00057	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CDC42—adrenal gland cancer	1.99e-05	0.000546	CbGpPWpGaD
Fenoldopam—ADRA2C—GPCR downstream signaling—POMC—adrenal gland cancer	1.98e-05	0.000545	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CDC42—adrenal gland cancer	1.96e-05	0.000538	CbGpPWpGaD
Fenoldopam—ADRA1B—GPCR downstream signaling—POMC—adrenal gland cancer	1.95e-05	0.000536	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—PRKACA—adrenal gland cancer	1.95e-05	0.000535	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—POMC—adrenal gland cancer	1.93e-05	0.000529	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—POMC—adrenal gland cancer	1.92e-05	0.000528	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—PRKACA—adrenal gland cancer	1.92e-05	0.000527	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IGF2—adrenal gland cancer	1.91e-05	0.000526	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—BRAF—adrenal gland cancer	1.9e-05	0.000522	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—GNAS—adrenal gland cancer	1.9e-05	0.000521	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PRKACA—adrenal gland cancer	1.89e-05	0.00052	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IGF2—adrenal gland cancer	1.89e-05	0.000519	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—GNAS—adrenal gland cancer	1.89e-05	0.000519	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—GNAS—adrenal gland cancer	1.87e-05	0.000514	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—ABCB1—adrenal gland cancer	1.85e-05	0.000509	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—IGF1R—adrenal gland cancer	1.85e-05	0.000508	CbGpPWpGaD
Fenoldopam—DRD5—Signaling by GPCR—EGFR—adrenal gland cancer	1.84e-05	0.000506	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—IGF1R—adrenal gland cancer	1.83e-05	0.000502	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—POMC—adrenal gland cancer	1.8e-05	0.000494	CbGpPWpGaD
Fenoldopam—DRD2—GPCR downstream signaling—POMC—adrenal gland cancer	1.8e-05	0.000494	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—POMC—adrenal gland cancer	1.77e-05	0.000487	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CDC42—adrenal gland cancer	1.77e-05	0.000486	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—PRKACA—adrenal gland cancer	1.77e-05	0.000486	CbGpPWpGaD
Fenoldopam—ADRA1A—GPCR downstream signaling—POMC—adrenal gland cancer	1.73e-05	0.000476	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IGF2—adrenal gland cancer	1.71e-05	0.000468	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—PRKACA—adrenal gland cancer	1.7e-05	0.000468	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—GNAS—adrenal gland cancer	1.69e-05	0.000464	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CDC42—adrenal gland cancer	1.65e-05	0.000454	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—IGF1R—adrenal gland cancer	1.65e-05	0.000453	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—POMC—adrenal gland cancer	1.63e-05	0.000449	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CDC42—adrenal gland cancer	1.63e-05	0.000447	CbGpPWpGaD
Fenoldopam—ADRA2A—GPCR downstream signaling—POMC—adrenal gland cancer	1.61e-05	0.000442	CbGpPWpGaD
Fenoldopam—ADRA2B—Hemostasis—TP53—adrenal gland cancer	1.59e-05	0.000438	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TERT—adrenal gland cancer	1.59e-05	0.000438	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IGF2—adrenal gland cancer	1.59e-05	0.000438	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—PRKACA—adrenal gland cancer	1.58e-05	0.000435	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—GNAS—adrenal gland cancer	1.58e-05	0.000434	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—POMC—adrenal gland cancer	1.57e-05	0.000432	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TERT—adrenal gland cancer	1.57e-05	0.000432	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IGF2—adrenal gland cancer	1.57e-05	0.000431	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—GNAS—adrenal gland cancer	1.55e-05	0.000427	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—IGF1R—adrenal gland cancer	1.54e-05	0.000423	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—GNAS—adrenal gland cancer	1.53e-05	0.000421	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—IGF1R—adrenal gland cancer	1.52e-05	0.000416	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—ABCB1—adrenal gland cancer	1.51e-05	0.000414	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CDC42—adrenal gland cancer	1.5e-05	0.000412	CbGpPWpGaD
Fenoldopam—ADRA2C—Hemostasis—TP53—adrenal gland cancer	1.49e-05	0.000409	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—POMC—adrenal gland cancer	1.46e-05	0.000402	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IGF2—adrenal gland cancer	1.45e-05	0.000397	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CDC42—adrenal gland cancer	1.44e-05	0.000397	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—GNAS—adrenal gland cancer	1.43e-05	0.000394	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TERT—adrenal gland cancer	1.42e-05	0.00039	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—IGF1R—adrenal gland cancer	1.4e-05	0.000384	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IGF2—adrenal gland cancer	1.39e-05	0.000383	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—BAD—adrenal gland cancer	1.39e-05	0.000381	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—GNAS—adrenal gland cancer	1.38e-05	0.000379	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—CTNNB1—adrenal gland cancer	1.37e-05	0.000377	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—BAD—adrenal gland cancer	1.37e-05	0.000376	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—IGF1R—adrenal gland cancer	1.35e-05	0.00037	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CDC42—adrenal gland cancer	1.34e-05	0.000369	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TERT—adrenal gland cancer	1.33e-05	0.000364	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TERT—adrenal gland cancer	1.3e-05	0.000358	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IGF2—adrenal gland cancer	1.29e-05	0.000355	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—GNAS—adrenal gland cancer	1.28e-05	0.000352	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—POMC—adrenal gland cancer	1.28e-05	0.000351	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—POMC—adrenal gland cancer	1.27e-05	0.000349	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—BRAF—adrenal gland cancer	1.26e-05	0.000347	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—POMC—adrenal gland cancer	1.26e-05	0.000346	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—IGF1R—adrenal gland cancer	1.25e-05	0.000344	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—BRAF—adrenal gland cancer	1.25e-05	0.000342	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—BAD—adrenal gland cancer	1.23e-05	0.000339	CbGpPWpGaD
Fenoldopam—DRD1—Signaling by GPCR—EGFR—adrenal gland cancer	1.22e-05	0.000336	CbGpPWpGaD
Fenoldopam—ADRA2A—Hemostasis—TP53—adrenal gland cancer	1.21e-05	0.000332	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling by GPCR—EGFR—adrenal gland cancer	1.21e-05	0.000332	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TERT—adrenal gland cancer	1.2e-05	0.00033	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TERT—adrenal gland cancer	1.16e-05	0.000318	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—BAD—adrenal gland cancer	1.15e-05	0.000317	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—POMC—adrenal gland cancer	1.14e-05	0.000313	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—BAD—adrenal gland cancer	1.14e-05	0.000312	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—BRAF—adrenal gland cancer	1.12e-05	0.000309	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling by GPCR—EGFR—adrenal gland cancer	1.09e-05	0.000299	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—EGFR—adrenal gland cancer	1.09e-05	0.000299	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TERT—adrenal gland cancer	1.08e-05	0.000296	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—POMC—adrenal gland cancer	1.06e-05	0.000292	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—BRAF—adrenal gland cancer	1.05e-05	0.000288	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—BAD—adrenal gland cancer	1.05e-05	0.000288	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—POMC—adrenal gland cancer	1.05e-05	0.000287	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—BRAF—adrenal gland cancer	1.03e-05	0.000284	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—POMC—adrenal gland cancer	1.03e-05	0.000284	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling by GPCR—EGFR—adrenal gland cancer	1.02e-05	0.00028	CbGpPWpGaD
Fenoldopam—ADRA2C—Metabolism—PTGS2—adrenal gland cancer	1.01e-05	0.000279	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—BAD—adrenal gland cancer	1.01e-05	0.000277	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling by GPCR—EGFR—adrenal gland cancer	1e-05	0.000275	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—POMC—adrenal gland cancer	9.65e-06	0.000265	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—BRAF—adrenal gland cancer	9.53e-06	0.000262	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—BAD—adrenal gland cancer	9.37e-06	0.000257	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—POMC—adrenal gland cancer	9.29e-06	0.000255	CbGpPWpGaD
Fenoldopam—DRD2—Signaling by GPCR—EGFR—adrenal gland cancer	9.23e-06	0.000254	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—BRAF—adrenal gland cancer	9.18e-06	0.000252	CbGpPWpGaD
Fenoldopam—DRD5—Signaling Pathways—TP53—adrenal gland cancer	9.13e-06	0.000251	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	9.12e-06	0.000251	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—CTNNB1—adrenal gland cancer	9e-06	0.000247	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling by GPCR—EGFR—adrenal gland cancer	8.9e-06	0.000244	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—POMC—adrenal gland cancer	8.64e-06	0.000237	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—BRAF—adrenal gland cancer	8.53e-06	0.000234	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling by GPCR—EGFR—adrenal gland cancer	8.27e-06	0.000227	CbGpPWpGaD
Fenoldopam—ADRA2A—Metabolism—PTGS2—adrenal gland cancer	8.24e-06	0.000226	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—CTNNB1—adrenal gland cancer	8.12e-06	0.000223	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—CTNNB1—adrenal gland cancer	7.59e-06	0.000208	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—CTNNB1—adrenal gland cancer	7.47e-06	0.000205	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—EGFR—adrenal gland cancer	7.22e-06	0.000198	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—EGFR—adrenal gland cancer	7.13e-06	0.000196	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—CTNNB1—adrenal gland cancer	6.89e-06	0.000189	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—CTNNB1—adrenal gland cancer	6.63e-06	0.000182	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—EGFR—adrenal gland cancer	6.44e-06	0.000177	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—CTNNB1—adrenal gland cancer	6.16e-06	0.000169	CbGpPWpGaD
Fenoldopam—DRD1—Signaling Pathways—TP53—adrenal gland cancer	6.07e-06	0.000167	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—EGFR—adrenal gland cancer	6.01e-06	0.000165	CbGpPWpGaD
Fenoldopam—ADRA1D—Signaling Pathways—TP53—adrenal gland cancer	5.99e-06	0.000164	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—EGFR—adrenal gland cancer	5.92e-06	0.000163	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—EGFR—adrenal gland cancer	5.45e-06	0.00015	CbGpPWpGaD
Fenoldopam—ADRA2B—Signaling Pathways—TP53—adrenal gland cancer	5.4e-06	0.000148	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—EGFR—adrenal gland cancer	5.26e-06	0.000144	CbGpPWpGaD
Fenoldopam—ADRA2C—Signaling Pathways—TP53—adrenal gland cancer	5.05e-06	0.000139	CbGpPWpGaD
Fenoldopam—ADRA1B—Signaling Pathways—TP53—adrenal gland cancer	4.97e-06	0.000136	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—EGFR—adrenal gland cancer	4.88e-06	0.000134	CbGpPWpGaD
Fenoldopam—DRD2—Signaling Pathways—TP53—adrenal gland cancer	4.58e-06	0.000126	CbGpPWpGaD
Fenoldopam—ADRA1A—Signaling Pathways—TP53—adrenal gland cancer	4.41e-06	0.000121	CbGpPWpGaD
Fenoldopam—ADRA2A—Signaling Pathways—TP53—adrenal gland cancer	4.1e-06	0.000113	CbGpPWpGaD
